Applied Biosciences Corp.
APPB
$0.00
$0.000.00%
| 12/31/2019 | 09/30/2019 | ||||
|---|---|---|---|---|---|
| Revenue | -30.58% | 15.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -30.58% | 15.51% | |||
| Cost of Revenue | -47.87% | -1.40% | |||
| Gross Profit | -18.99% | 30.62% | |||
| SG&A Expenses | 13.01% | 67.42% | |||
| Depreciation & Amortization | 2.77% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.01% | 53.65% | |||
| Operating Income | -18.20% | -70.36% | |||
| Income Before Tax | -66.73% | -68.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -66.73% | -68.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -6.45% | -7.74% | |||
| Net Income | -74.03% | -83.46% | |||
| EBIT | -18.20% | -70.36% | |||
| EBITDA | -18.93% | -76.72% | |||
| EPS Basic | -71.63% | -88.27% | |||
| Normalized Basic EPS | -32.74% | -100.59% | |||
| EPS Diluted | -71.63% | -88.27% | |||
| Normalized Diluted EPS | -32.74% | -100.59% | |||
| Average Basic Shares Outstanding | 1.36% | -2.46% | |||
| Average Diluted Shares Outstanding | 1.36% | -2.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
